Anne Vanlent, Director at Aegerion Pharmaceuticals, Inc. (AEGR), bought 4,000 shares at $33.20 ($135K) on 2014-05-08, disclosed to the SEC on 2014-05-09.
Open-market purchase of $135k AEGR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.20 | 2,000 | $66K | 49.1% |
| 2 | $34.33 | 1,948 | $67K | 49.5% |
| 3 | $35.29 | 52 | $2K | 1.4% |
| Total | $33.78 avg | 4,000 | $135K | 100% |
| Filing → |
| IART | SELL | 2011-01-14 | $250K | — | Filing → |
| PPCO | SELL | 2008-11-10 | $7K | — | Filing → |